Multimodality Approach to Management of Stage III Non-Small Cell Lung Cancer

被引：8

作者：

Scarpaci, Anthony ^{[1
]}

Mitra, Priya ^{[1
]}

Jarrar, Doraid ^{[1
]}

Masters, Gregory A. ^{[2
]}

机构：

[1] Albert Einstein Med Ctr Philadelphia, Philadelphia, PA 19141 USA

[2] Helen F Graham Canc Ctr, Newark, DE 19713 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 22卷 / 02期

关键词：

Non small cell lung cancer; Neoadjuvant treatment; Multimodality approach; CHEMOTHERAPY; CARBOPLATIN; PACLITAXEL; SURGERY; TRIAL;

D O I：

10.1016/j.soc.2012.12.014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multimodality Approach to Management of Stage Ill Non Small Cell Lung Cancer Anthony Scarpaci, Priya Mitra, Doraid Jarrar, and Gregory A. Masters Stage ill non small cell lung cancer represents a heterogeneous group of patients who are best managed with a multidisciplinary approach, including evaluation for surgical, radiation, and chemotherapeutic options.

引用

页码：319 / +

页数：11

共 50 条

[21] Multimodality management of non-small cell lung cancer patients with brain metastases
Ricciardi, Serena
de Marinis, Filippo
CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 86 - 93
[22] The serial effects of multimodality therapy for stage III non-small cell carcinoma on lung function
Mazzone, P. J.
Videtic, G.
Murthy, S.
Mason, D.
Rice, T.
Pennell, N.
Rich, T.
Machuzak, M.
Mekhail, T.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[23] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Price, Katharine A. R.
Azzoli, Christopher G.
Gaspar, Laurie E.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
[24] Neoadjuvant Chemoradiotherapy for Stage iii Non-Small Cell Lung Cancer
Sher, David J.
FRONTIERS IN ONCOLOGY, 2017, 7
[25] Surgical treatment of stage III non-small cell lung cancer
Orlowski, TM
Szczesny, TJ
LUNG CANCER, 2001, 34 : S137 - S143
[26] Advances in the Treatment of Stage III Non-Small Cell Lung Cancer
Myall, Nathaniel J.
Das, Millie
CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 211 - +
[27] RADIOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC)
De Ruysscher, D.
LUNG CANCER, 2009, 64 : S21 - S21
[28] The role of biomarkers in stage III non-small cell lung cancer
Rosell, Rafael
Gonzalez-Cao, Maria
Ito, Masaoki
Santarpia, Mariacarmela
Aguilar, Andres
Codony-Servat, Jordi
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (06) : 469 - 480
[29] The role of radiotherapy in stage III non-small cell lung cancer
Jassem, J.
LUNG CANCER, 2006, 52 : S4 - S5
[30] Audit of stage III non-small cell lung cancer (NSCLC) management in the Essex Cancer Network
Reinius, M.
Malek, A.
Powrie, D.
Yung, B.
Ingle, C.
Islam, M. R.
Dancey, G.
LUNG CANCER, 2019, 127 : S8 - S8

← 1 2 3 4 5 →